ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Hugh F. Burnett
Charles H. Miller
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, G. D.
Right arrow Articles by Miller, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, G. D.
Right arrow Articles by Miller, C. H.

Ann Thorac Surg 1976;22:322-329
© 1976 The Society of Thoracic Surgeons


Articles

Retrograde Venous Cardiac Perfusion for Myocardial Revascularization

An Experimental Evaluation

G. Doyne Williams, M.D.*, Hugh F. Burnett, M.D., Bobby L. Derrick, M.D., Charles H. Miller, M.D.

Department of Surgery, University of Arkansas for Medical Sciences, Little Rock, AR.

* Address reprint requests to Dr. Williams, Department of Surgery, University of Arkansas for Medical Sciences, 4301 W Markham, Little Rock, AR 72201.

This study evaluates cardiac function in dogs during retrograde perfusion through the coronary sinus. Five hearts perfused retrograde in an ex vivo apparatus demonstrated rapid and marked increases in weight and perfusion pressure, became hemorrhagic, and contracted poorly within one hour. Five similarly perfused hearts treated with phenoxybenzamine experienced no increase in weight or perfusion pressure and maintained good color and contractions for up to one hour. Five additional hearts treated with phenoxybenzamine did not develop hemorrhage, edema, increased weight, or increased perfusion pressure but could maintain the systemic circulation for only brief periods after 15 minutes of intermittent cardiopulmonary bypass support.

We conclude that cardiac viability can be maintained with retrograde perfusion enhanced with alpha blocking agents. However, hearts so perfused cannot maintain adequate systemic pressure. The data suggest that extensive myocardial revascularization through the retrograde venous route would be ineffective.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. S. Hochberg and W. G. Austen
Selective Retrograde Coronary Venous Perfusion
Ann. Thorac. Surg., June 1, 1980; 29(6): 578 - 588.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. J. Bates, M. Toscano, S. C. Balderman, and C. E. Anagnostopoulos
The Cardiac Veins and Retrograde Coronary Venous Perfusion
Ann. Thorac. Surg., January 1, 1977; 23(1): 83 - 90.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1976 by The Society of Thoracic Surgeons.